AKZO NOBEL NV (AKZOY) Form 10-Q Quarterly Reports
AKZO NOBEL NV (AKZOY) is a publicly traded company on the OTC, categorized under SIC 2800 (Chemicals & Allied Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AKZOY
CIK: 3124
Exchange: OTC
SIC 2800: Chemicals & Allied Products
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers Accountants N.V.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerDennis van Ameijden
Audit LocationAmsterdam, Netherlands
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 425 | 2026-10-16 | — | FORM 425 | 0000950103-26-015694 | View SEC Doc Filr Page |
| 6-K | 2026-10-16 | 2026-10-16 | FORM 6-K | 0000950103-26-015693 | View SEC Doc Filr Page |
| 425 | 2026-10-15 | — | FORM 425 | 0000950103-26-015665 | View SEC Doc Filr Page |
| 425 | 2026-10-15 | — | FORM 425 | 0000950103-26-015661 | View SEC Doc Filr Page |
| 6-K | 2026-10-15 | 2026-10-15 | FORM 6-K | 0000950103-26-015660 | View SEC Doc Filr Page |
| 425 | 2026-10-05 | — | FORM 425 | 0000950103-26-015190 | View SEC Doc Filr Page |
| 6-K | 2026-10-05 | 2026-10-05 | FORM 6-K | 0000950103-26-015189 | View SEC Doc Filr Page |
| 425 | 2026-08-31 | — | FORM 425 | 0000950103-26-013228 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | FORM 6-K | 0000950103-26-013227 | View SEC Doc Filr Page |
| 6-K | 2026-08-07 | 2026-08-07 | FORM 6-K | 0000950103-26-012056 | View SEC Doc Filr Page |
| 425 | 2026-08-05 | — | FORM 425 | 0000950103-26-011930 | View SEC Doc Filr Page |
| 424B3 | 2026-07-29 | — | 424B3 | 0001193125-26-322163 | View SEC Doc Filr Page |
| 6-K | 2026-07-23 | 2026-07-23 | FORM 6-K | 0000950103-26-011045 | View SEC Doc Filr Page |
| 424B3 | 2026-07-22 | — | 424B3 | 0001193125-26-311874 | View SEC Doc Filr Page |
| 6-K | 2026-07-22 | 2026-07-22 | 6-K | 0001193125-26-311872 | View SEC Doc Filr Page |
| 6-K | 2026-07-22 | 2026-07-22 | 6-K | 0001193125-26-311868 | View SEC Doc Filr Page |
| 6-K | 2026-07-13 | 2026-07-13 | FORM 6-K | 0000950103-26-010551 | View SEC Doc Filr Page |
| 425 | 2026-07-13 | — | FORM 425 | 0000950103-26-010542 | View SEC Doc Filr Page |
| 425 | 2026-06-26 | — | FORM 425 | 0000950103-26-009534 | View SEC Doc Filr Page |
| 425 | 2026-06-24 | — | FORM 425 | 0000950103-26-009428 | View SEC Doc Filr Page |
| 425 | 2026-06-24 | — | FORM 425 | 0000950103-26-009427 | View SEC Doc Filr Page |
| 424B3 | 2026-06-24 | — | 424B3 | 0001193125-26-280273 | View SEC Doc Filr Page |
| EFFECT | 2026-06-23 | — | EFFECT Filing | 9999999995-26-002088 | View SEC Doc Filr Page |
| 425 | 2026-06-23 | — | FORM 425 | 0000950103-26-009390 | View SEC Doc Filr Page |
| F-4/A | 2026-06-18 | — | F-4/A | 0001193125-26-275378 | View SEC Doc Filr Page |